Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Spatial transcriptomics has emerged as a powerful tool for discerning the heterogeneity of the tumour microenvironment across various cancers, including renal cell carcinoma (RCC). Spatial transcriptomics-based studies conducted in clear-cell RCC (the only RCC subtype studied using this technique to date) have given insights into spatial interactions within this disease. These insights include the role of epithelial-to-mesenchymal transitioning, revealing proximity-dependent interactions between tumour cells, fibroblasts, interleukin-2-expressing macrophages and hyalinized regions. Investigations into metabolic programmes have shown high transcriptional heterogeneity within tumours, with a tendency of increased metabolic activity towards the tumour centre. T cell infiltration has been shown to be independent of neoantigen burden, although T cell activity correlates with both metabolic states and various transcripts expressed by tumour cells, fibroblasts and monocytes. The role of tertiary lymphoid structures in both plasma cell maturation and their infiltration of the tumour has been shown through tracks of fibroblasts. Collectively, these findings indicate the potential of spatial transcriptomics to reveal predictive spatial features, supporting its promise in the development of biomarkers for clear-cell RCC management.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such findings are frequently reported in bulk tumor transcriptome studies and likely reflect the intricate interplay between malignant cells and the tumor microenvironment (TME) [59–61].”
From PPP1R18-mediated activation of Wnt/β-catenin and EMT is dependent on ERK signaling in clear cell renal cell carcinoma (2026) · cites this paper as [60]
Citations
Cites
Yang (2021) · doi:10.1038/s41598-020-79139-8 · Cited by 5,035
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656 · cited 2×
“RCC tumours have repeatedly been shown to be highly heterogeneous at the level of mutations 4,5 , transcriptomic programmes 7 and immune cell infiltration 6 , and, therefore, multiple samples per tumour are likely to be necessary to capture the biological diversity.”
Hsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D. Y., Larkin, J., & Ficarra, V. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.9 · Cited by 2,426
Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution
Rodriques, S. G., Stickels, R. R., Goeva, A., Martin, C. A., Murray, E., Vanderburg, C. R., Welch, J., Chen, L. M., Chen, F., & Macosko, E. Z. (2019) · Science · doi:10.1126/science.aaw1219 · Cited by 2,424
Exploring tissue architecture using spatial transcriptomics
Rao, A., Barkley, D., França, G. S., & Yanai, I. (2021) · Nature · doi:10.1038/s41586-021-03634-9 · Cited by 1,700
Three-dimensional intact-tissue sequencing of single-cell transcriptional states
Wang, X., Allen, W. E., Wright, M. A., Sylwestrak, E. L., Samusik, N., Vesuna, S., Evans, K., Liu, C., Ramakrishnan, C., Liu, J., et al. (2018) · Science · doi:10.1126/science.aat5691 · Cited by 1,620
High-definition spatial transcriptomics for in situ tissue profiling
Vickovic, S., Eraslan, G., Salmén, F., Klughammer, J., Stenbeck, L., Schapiro, D., Äijö, T., Bonneau, R., Bergenstråhle, L., Navarro, J. F., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0548-y · Cited by 1,150
Multiplex digital spatial profiling of proteins and RNA in fixed tissue
Merritt, C. R., Ong, G. T., Church, S. E., Barker, K., Danaher, P., Geiss, G., Hoang, M., Jung, J., Liang, Y., McKay-Fleisch, J., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0472-9 · Cited by 1,072
Meylan, M., Petitprez, F., Becht, E., Bougoüin, A., Pupier, G., Calvez, A., Giglioli, I., Verkarre, V., Lacroix, G., Verneau, J., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.02.001 · Cited by 831 · cited 9×
“The presence of tertiary lymphoid structures (TLS) was detected within ccRCC tumours and distinct gene signatures associated with immune cell localization within TLS areas were identified 16 .”
InfluentialHe, S., Bhatt, R., Brown, C., Brown, E. A., Buhr, D. L., Chantranuvatana, K., Danaher, P., Dunaway, D., Garrison, R. G., Geiss, G., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01483-z · Cited by 814 · cited 2×
“Imager 14 ; Fig.”
Cited by
Current Role and Future Frontiers of Spatial Transcriptomics in Genitourinary Cancers
Hatoum, F., Fazili, A. N., Miller, J. W., Wang, X., Yu, X., Lü, X., Johnson, J. S., Spiess, P. E., & Chahoud, J. (2025) · Cancers · doi:10.3390/cancers17172774 · Cited by 4
“The integration of ST into clinical practice represents an emerging area of advancement in cancer diagnostics; however, rigorous validation is still needed to bridge the gap between research findings and routine clinical practice [14,28,36,60].”
Enhancing spatial transcriptomics in clear-cell renal cell carcinoma
Li, C., Sheng, J., & Wu, G. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01085-9 · Cited by 3
“Despite these areas for improvement, the Review 1 substantially contributes to our understanding of ccRCC through spatial transcriptomics.”
Niu, Y., Su, Y., Wang, X., Yang, X., & Zhong, D. (2026) · PLoS ONE · doi:10.1371/journal.pone.0344424 · Cited by 2
“Principal component analysis (PCA) of transcriptomic data from 73 ccRCC patients demonstrates significant transcriptomic divergence between younger and older patients, with PC1 effectively segregating age groups (p = 0.04) [16].”
InfluentialJi, X., Yun, Y., Zhu, Z., Wu, T., Ruan, M., Fan, Y., & Zhang, Q. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04266-7
“First, while we have validated the oncogenic role of PPP1R18 in vivo using a xenograft model, the tumor microenvironment is complex, and further studies are needed to fully understand the role of PPP1R18 in this context [60].”
Reply to ‘Enhancing spatial transcriptomics in clear-cell renal cell carcinoma’
Jespersen, J. H., & Lyskjær, I. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01086-8
“In our Review 1 , we highlight spatial heterogeneity in immunotherapy-exposed tumours, such as epithethial-to-mesenchymal upregulation and increased exhaustion markers, but we concur that dynamic plasticity of the tumour microenvironment warrants further exploration.”
InfluentialSelf-citation
Metadata
- Authors
- Jespersen, J., Lindgaard, C., Iisager, L., Ahrenfeldt, J., & Lyskjær, I.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Lyskjær, Iben
- Venue
- Nature Reviews Urology
- Published
- 2025-01-09
- Volume
- 22
- Issue
- 11
- Pages
- 726-734
- ISSN
- 1759-4812 (ISSN-L)
- 1759-4820
- OpenAlex
- W4406235088
- Cited by
- 12
- References
- 48
- Citations by year
- 2026: 9 · 2025: 3
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Urology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Lundbeckfonden (R413-2022-606)
- Topics
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- clear cell renal cell carcinoma, spatial transcriptomics, tumor microenvironment, tumor heterogeneity, epithelial-mesenchymal transition, cancer metabolism, T cell infiltration, neoantigens, tertiary lymphoid structures, plasma cell maturation, biomarkers
- MeSH terms
- Carcinoma, Renal Cell, Humans, Kidney Neoplasms, Gene Expression Profiling, Epithelial-Mesenchymal Transition, Tumor Microenvironment, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma. https://app.cochat.ai/papers/10.1038/s41585-024-00980-x
- The paper
- Jespersen, J., Lindgaard, C., Iisager, L., Ahrenfeldt, J., & Lyskjær, I. (2025). Lessons learned from spatial transcriptomic analyses in clear-cell renal cell carcinoma. Nature Reviews Urology. https://doi.org/10.1038/s41585-024-00980-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.